RxDoctor Payments Data

Norma Jacquez

Primary Care · El Paso, TXNPI 1013593029

Payments from drug & device makers

$2,035in general payments, 2019–2025

Across 94 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$372
  • Biohaven Pharmaceutical Holding Company Ltd.$199
  • GSK$199
  • Novo Nordisk$158
  • Neurocrine Biosciences, Inc.$129
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$111
  • plus $868 from 22 others

What the payments were for

  • Food & beverage$2,035100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,035 in reported general payments places this provider in the 80th percentile of 563 primary care providers in Texas.

See all primary care providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide29$51,132
JardianceEmpagliflozin14$9,074
LinzessLinaclotide12$6,496
Omega-3 Acid Ethyl Esters32$5,623
Solifenacin Succinate17$787
Omeprazole36$785
Lidocaine11$765
Duloxetine Hcl11$755
Diclofenac Sodium17$683
Metformin Hcl51$555
Atorvastatin Calcium57$473
Gabapentin22$408
Losartan Potassium31$353
Tamsulosin Hcl30$274
Albuterol Sulfate HfaAlbuterol Sulfate16$254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$90$51,13229 claims
Boehringer IngelheimJardiance$55$9,07414 claims
AbbVieLinzess$372$6,49612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 563 primary care providers in Texas.

Other primary care in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →